Hosted on MSN3h
For Your Patients: What Is Multiple Myeloma?
Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...
emjreviews.com6h
High-Risk Genetic Markers Predict Poor Outcomes in Multiple Myeloma
Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.
Medpage Today on MSN12h
The Basics of Multiple Myeloma
In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...
"There’s No Cure Without Us”: One Woman’s Mission To Transform Awareness And Care For Black Patients With Multiple Myeloma
After being diagnosed with multiple myeloma, Valarie Traynham turned her journey into a mission—raising awareness, educating ...
Wānaka blood cancer patient, 36, to get cutting-edge CAR T-cell therapy in China - why experts want the therapy here
Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...
Rolling Out6d
A rare cancer, modified cells, and the future they promised
A couple facing a terminal multiple myeloma diagnosis finds renewed hope through innovative immunotherapy, transforming blood ...
rheumatologyadvisor6d
FDA Approves Denosumab Biosimilars Ospomyv and Xbryk
The FDA has approved the BLA for Ospomyv™ and Xbryk™, biosimilars to Prolia (denosumab) and Xgeva (denosumab), respectively.